Innovations and changes in the ICD-11 classification of mental, behavioural and neurodevelopmental disorders.

ICD-11 International Classification of Diseases clinical utility culture-related guidance diagnosis dimensional approaches mental disorders

Journal

World psychiatry : official journal of the World Psychiatric Association (WPA)
ISSN: 1723-8617
Titre abrégé: World Psychiatry
Pays: Italy
ID NLM: 101189643

Informations de publication

Date de publication:
Feb 2019
Historique:
entrez: 3 1 2019
pubmed: 3 1 2019
medline: 3 1 2019
Statut: ppublish

Résumé

Following approval of the ICD-11 by the World Health Assembly in May 2019, World Health Organization (WHO) member states will transition from the ICD-10 to the ICD-11, with reporting of health statistics based on the new system to begin on January 1, 2022. The WHO Department of Mental Health and Substance Abuse will publish Clinical Descriptions and Diagnostic Guidelines (CDDG) for ICD-11 Mental, Behavioural and Neurodevelopmental Disorders following ICD-11's approval. The development of the ICD-11 CDDG over the past decade, based on the principles of clinical utility and global applicability, has been the most broadly international, multilingual, multidisciplinary and participative revision process ever implemented for a classification of mental disorders. Innovations in the ICD-11 include the provision of consistent and systematically characterized information, the adoption of a lifespan approach, and culture-related guidance for each disorder. Dimensional approaches have been incorporated into the classification, particularly for personality disorders and primary psychotic disorders, in ways that are consistent with current evidence, are more compatible with recovery-based approaches, eliminate artificial comorbidity, and more effectively capture changes over time. Here we describe major changes to the structure of the ICD-11 classification of mental disorders as compared to the ICD-10, and the development of two new ICD-11 chapters relevant to mental health practice. We illustrate a set of new categories that have been added to the ICD-11 and present the rationale for their inclusion. Finally, we provide a description of the important changes that have been made in each ICD-11 disorder grouping. This information is intended to be useful for both clinicians and researchers in orienting themselves to the ICD-11 and in preparing for implementation in their own professional contexts.

Identifiants

pubmed: 30600616
doi: 10.1002/wps.20611
pmc: PMC6313247
doi:

Types de publication

Journal Article

Langues

eng

Pagination

3-19

Subventions

Organisme : World Health Organization
ID : 001
Pays : International
Organisme : Department of Health
ID : 07/01/26
Pays : United Kingdom

Informations de copyright

© 2019 World Psychiatric Association.

Références

Acta Psychiatr Scand. 2004 Feb;109(2):150-5; discussion 155
pubmed: 14725599
JAMA. 2005 Jun 1;293(21):2601-8
pubmed: 15928281
J Nerv Ment Dis. 2006 Oct;194(10):785-90
pubmed: 17041292
Psychosomatics. 2007 Sep-Oct;48(5):369-78
pubmed: 17878494
Bipolar Disord. 2008 Feb;10(1 Pt 2):163-78
pubmed: 18199235
Br J Psychiatry. 2008 Mar;192(3):171-7
pubmed: 18310574
Neurosci Lett. 2009 May 29;456(1):44-8
pubmed: 19429131
Psychol Med. 2010 Feb;40(2):273-88
pubmed: 19515267
Int J Eat Disord. 2009 Dec;42(8):687-705
pubmed: 19621466
Bipolar Disord. 2010 May;12(3):312-8
pubmed: 20565438
Psychol Med. 2011 Sep;41(9):1791-803
pubmed: 21275085
World Psychiatry. 2011 Jun;10(2):86-92
pubmed: 21633677
World Psychiatry. 2011 Jun;10(2):118-31
pubmed: 21633689
Psychol Med. 2012 Jan;42(1):1-13
pubmed: 21733222
J Clin Psychiatry. 2011 Jun;72(6):780-6; quiz 878-9
pubmed: 21733479
World Psychiatry. 2011 Oct;10(3):175-80
pubmed: 21991267
Psychopathology. 2012;45(1):3-14
pubmed: 22123511
Am J Psychiatry. 2012 Jun;169(6):577-88
pubmed: 22535310
Genes Brain Behav. 2012 Jul;11(5):524-8
pubmed: 22548711
World Psychiatry. 2012 Jun;11(2):80-92
pubmed: 22654933
Arch Gen Psychiatry. 2012 Nov;69(11):1131-9
pubmed: 22752056
Br J Psychiatry. 2012 Jul;201(1):9-10
pubmed: 22753851
Am J Psychiatry. 2012 May;169(5):465-75
pubmed: 22764360
Schizophr Bull. 2012 Sep;38(5):895-8
pubmed: 22987845
Int Rev Psychiatry. 2012 Oct;24(5):463-6
pubmed: 23057982
Psychiatr Danub. 2012 Oct;24 Suppl 3:S311-5
pubmed: 23114808
Int Rev Psychiatry. 2012 Dec;24(6):578-90
pubmed: 23244613
Int J Psychol. 2013;48(3):177-93
pubmed: 23750927
World Psychiatry. 2013 Oct;12(3):198-206
pubmed: 24096776
J Clin Psychol. 2013 Dec;69(12):1191-212
pubmed: 24122386
Braz J Psychiatry. 2014;36 Suppl 1:14-20
pubmed: 25388608
Braz J Psychiatry. 2014;36 Suppl 1:28-39
pubmed: 25388610
Braz J Psychiatry. 2014;36 Suppl 1:59-64
pubmed: 25388613
World Psychiatry. 2015 Feb;14(1):30-3
pubmed: 25655147
World Psychiatry. 2015 Feb;14(1):82-90
pubmed: 25655162
Lancet. 2015 Feb 21;385(9969):717-26
pubmed: 25706217
J Affect Disord. 2016 Jan 15;190:663-674
pubmed: 26590514
Am Psychol. 2016 Jan;71(1):3-16
pubmed: 26766762
Addict Biol. 2017 Jul;22(4):885-897
pubmed: 26935000
Lancet Psychiatry. 2016 Jun;3(6):579-84
pubmed: 27133547
Depress Anxiety. 2016 Dec;33(12):1141-1154
pubmed: 27411108
World Psychiatry. 2016 Oct;15(3):291-292
pubmed: 27717252
World Psychiatry. 2016 Oct;15(3):205-221
pubmed: 27717275
World Psychiatry. 2017 Feb;16(1):100-101
pubmed: 28127909
Clin Psychol Rev. 2017 Apr;53:29-45
pubmed: 28192774
Arch Sex Behav. 2017 Jul;46(5):1529-1545
pubmed: 28210933
Fam Pract. 2017 Sep 1;34(5):574-580
pubmed: 28475675
J Behav Addict. 2017 Sep 1;6(3):271-279
pubmed: 28816494
Clin Psychol Rev. 2017 Dec;58:1-15
pubmed: 29029837
Epidemiol Psychiatr Sci. 2018 Jun;27(3):212-218
pubmed: 29198240
Psychol Sci Public Interest. 2017 Sep;18(2):72-145
pubmed: 29211974
World Psychiatry. 2018 Feb;17(1):109-110
pubmed: 29352554
World Psychiatry. 2018 Jun;17(2):229-230
pubmed: 29856541
World Psychiatry. 2018 Jun;17(2):227-229
pubmed: 29856549
World Psychiatry. 2018 Jun;17(2):187-195
pubmed: 29856559
World Psychiatry. 2018 Jun;17(2):224-225
pubmed: 29856565
World Psychiatry. 2018 Jun;17(2):174-186
pubmed: 29856568
Psychol Med. 2018 Jun 4;:1-8
pubmed: 29860958
Schizophr Res. 2018 Dec;202:254-259
pubmed: 30017460
World Psychiatry. 2018 Oct;17(3):363-364
pubmed: 30192089
World Psychiatry. 2018 Oct;17(3):306-315
pubmed: 30192090
World Psychiatry. 2018 Oct;17(3):282-293
pubmed: 30229571
Int J Clin Health Psychol. 2016 May-Aug;16(2):109-127
pubmed: 30487855
J Intellect Disabil Res. 2019 Jan 9;:null
pubmed: 30628126

Auteurs

Geoffrey M Reed (GM)

Department of Mental Health and Substance Abuse, World Health Organization, Geneva, Switzerland.
Department of Psychiatry, Columbia University Medical Center, New York, NY, USA.

Michael B First (MB)

Department of Psychiatry, Columbia University Medical Center, New York, NY, USA.
New York State Psychiatric Institute, New York, NY, USA.

Cary S Kogan (CS)

School of Psychology, University of Ottawa, Ottawa, ON, Canada.

Steven E Hyman (SE)

Stanley Center for Psychiatric Research, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.

Oye Gureje (O)

Department of Psychiatry, University of Ibadan, Ibadan, Nigeria.

Wolfgang Gaebel (W)

Department of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.

Mario Maj (M)

Department of Psychiatry, University of Campania "L. Vanvitelli", Naples, Italy.

Dan J Stein (DJ)

Department of Psychiatry, University of Cape Town, and South African Medical Research Council Unit on Risk and Resilience in Mental Disorders, Cape Town, South Africa.

Andreas Maercker (A)

Department of Psychology, University of Zurich, Zurich, Switzerland.

Peter Tyrer (P)

Centre for Mental Health, Imperial College, London, UK.

Angelica Claudino (A)

Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP/EPM), São Paulo, Brazil.

Elena Garralda (E)

Centre for Mental Health, Imperial College, London, UK.

Luis Salvador-Carulla (L)

Research School of Population Health, Australian National University, Canberra, ACT, Australia.

Rajat Ray (R)

National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India.

John B Saunders (JB)

Centre for Youth Substance Abuse Research, University of Queensland, Brisbane, QLD, Australia.

Tarun Dua (T)

Department of Mental Health and Substance Abuse, World Health Organization, Geneva, Switzerland.

Vladimir Poznyak (V)

Department of Mental Health and Substance Abuse, World Health Organization, Geneva, Switzerland.

María Elena Medina-Mora (ME)

National Institute of Psychiatry Ramón de la Fuente Muñiz, Mexico City, Mexico.

Kathleen M Pike (KM)

Department of Psychiatry, Columbia University Medical Center, New York, NY, USA.

José L Ayuso-Mateos (JL)

Department of Psychiatry, Universidad Autonoma de Madrid; Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM); Instituto de Investigación Sanitaria La Princesa, Madrid, Spain.

Shigenobu Kanba (S)

Department of Neuropsychiatry, Kyushu University, Fukuoka, Japan.

Jared W Keeley (JW)

Department of Psychology, Virginia Commonwealth University, Richmond, VA, USA.

Brigitte Khoury (B)

Department of Psychiatry, American University of Beirut Medical Center, Beirut, Lebanon.

Valery N Krasnov (VN)

Moscow Research Institute of Psychiatry, National Medical Research Centre for Psychiatry and Narcology, Moscow, Russian Federation.

Maya Kulygina (M)

Moscow Research Institute of Psychiatry, National Medical Research Centre for Psychiatry and Narcology, Moscow, Russian Federation.

Anne M Lovell (AM)

Institut National de la Santé et de la Recherche Médicale U988, Paris, France.

Jair de Jesus Mari (J)

Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP/EPM), São Paulo, Brazil.

Toshimasa Maruta (T)

Health Management Center, Seitoku University, Matsudo, Japan.

Chihiro Matsumoto (C)

Japanese Society of Psychiatry and Neurology, Tokyo, Japan.

Tahilia J Rebello (TJ)

Department of Psychiatry, Columbia University Medical Center, New York, NY, USA.
New York State Psychiatric Institute, New York, NY, USA.

Michael C Roberts (MC)

Office of Graduate Studies and Clinical Child Psychology Program, University of Kansas, Lawrence, KS, USA.

Rebeca Robles (R)

National Institute of Psychiatry Ramón de la Fuente Muñiz, Mexico City, Mexico.

Pratap Sharan (P)

Department of Psychiatry, All India Institute of Medical Sciences, New Delhi, India.

Min Zhao (M)

Shanghai Mental Health Center and Department of Psychiatry, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.

Assen Jablensky (A)

Centre for Clinical Research in Neuropsychiatry, University of Western Australia, Perth, WA, Australia.

Pichet Udomratn (P)

Department of Psychiatry, Prince of Songkla University, Hat Yai, Thailand.

Afarin Rahimi-Movaghar (A)

Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran.

Per-Anders Rydelius (PA)

Department of Child and Adolescent Psychiatry, Karolinska Institute, Stockholm, Sweden.

Sabine Bährer-Kohler (S)

International Federation of Social Workers, Basel, Switzerland.

Ann D Watts (AD)

Entabeni Hospital, Durban, South Africa.

Shekhar Saxena (S)

Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Classifications MeSH